AstraZeneca to invest US$15bn in China manufacturing and R&D
PHARMACEUTICAL giant AstraZeneca has announced plans to invest US$15bn in China, deepening its presence in the country’s manufacturing and research ecosystem and citing China’s growing “scientific excellence”.










